Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
Figure 3
Serum TRAIL levels in AMI patient with respect to adverse clinical events.
Serum levels of TRAIL were analyzed in AMI patient who died or experienced HF (with events) either during the acute phase (in-hospital) or in the follow-up (12 months after AMI) with respect to the other AMI patients (without events). Horizontal bars are median, upper and lower edges of box are 75th and 25th percentiles, lines extending from box are 10th and 90th percentiles.